category,datetime,headline,id,image,related,source,summary,url
company,1768851600,Janus Henderson Enterprise Fund Q4 2025 Portfolio Review,138181613,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1441354501/image_1441354501.jpg?io=getty-c-w1536,CSGP,SeekingAlpha,"Janus Henderson Enterprise Fund Q4 2025 commentary examines performance drivers for J.B. Hunt and Revolution Medicines, alongside headwinds for Constellation Software and CoStar Group.",https://finnhub.io/api/news?id=d579cdb7d519bdc02f714291acad30f867fd36457f8328fe41efb98118150368
